Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKB β) inhibitors.
about
A combination of receptor-based pharmacophore modeling & QM techniques for identification of human chymase inhibitorsPharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plantsDocking Screens for Novel Ligands Conferring New Biology.Integrating sampling techniques and inverse virtual screening: toward the discovery of artificial peptide-based receptors for ligands.Structure-based screening, ADMET profiling, and molecular dynamic studies on mGlu2 receptor for identification of newer antiepileptic agents.A 2D-QSAR and Grid-Independent Molecular Descriptor (GRIND) Analysis of Quinoline-Type Inhibitors of Akt2: Exploration of the Binding Mode in the Pleckstrin Homology (PH) DomainSynthesis and sar study of diarylpentanoid analogues as new anti-inflammatory agents.Discovery of HIV-1 integrase inhibitors: pharmacophore mapping, virtual screening, molecular docking, synthesis, and biological evaluation.Probing voltage sensing domain of KCNQ2 channel as a potential target to combat epilepsy: a comparative study.Identification of InhA inhibitors: A combination of virtual screening, molecular dynamics simulations and quantum chemical studies.Discovery of small molecules through pharmacophore modeling, docking and molecular dynamics simulation against Plasmodium vivax Vivapain-3 (VP-3).Binding of anti-Trypanosoma natural products from African flora against selected drug targets: a docking study
P2860
Q28487136-C299ACF4-DA8A-4A85-9BF1-F50B59FE4F6EQ28596537-ACA40419-3C3C-4D38-BB2F-CA19F479B641Q30489011-A7818474-E3A5-47B3-A9AF-2F55CE985CC7Q35836731-EC9BF400-C281-4CA4-ADCD-2B3EBCA2EE38Q36185283-93B1F428-E6D8-4D6D-A6EC-BA57C4237D9FQ36236507-1181FDAE-BA72-4DDF-B45C-8001CC555F50Q38949143-D2528CB9-48D2-4FAF-8340-A961BDAF186AQ39108426-38B723F5-5C12-4750-9A5F-A2A933F28FF8Q50252143-91F65E06-C87D-4545-AE62-AB00815152D2Q53092961-0EC01A44-D36F-4D19-A751-E80FB5ECBEFFQ54978531-11ED3B30-948A-40AB-A77D-FC8F43ABF604Q58862088-F37C354A-5C2E-4A9E-A54A-7897A7876EF0
P2860
Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKB β) inhibitors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Pharmacophore modeling, virtua ...... n kinase B (PKB β) inhibitors.
@en
Pharmacophore modeling, virtua ...... n kinase B (PKB β) inhibitors.
@nl
type
label
Pharmacophore modeling, virtua ...... n kinase B (PKB β) inhibitors.
@en
Pharmacophore modeling, virtua ...... n kinase B (PKB β) inhibitors.
@nl
prefLabel
Pharmacophore modeling, virtua ...... n kinase B (PKB β) inhibitors.
@en
Pharmacophore modeling, virtua ...... n kinase B (PKB β) inhibitors.
@nl
P2093
P1476
Pharmacophore modeling, virtua ...... n kinase B (PKB β) inhibitors.
@en
P2093
Ashutosh Goel
Manjunath Ghate
Vivek K Vyas
P356
10.1016/J.JMGM.2013.01.010
P577
2013-02-24T00:00:00Z